Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-26T19:50:27.815Z Has data issue: false hasContentIssue false
  • English
  • Français

P02-206 - Multiple Deep Brain Stimulation Targets for Refractory Obsessive Compulsive Disorders

Published online by Cambridge University Press:  17 April 2020

A. Moura ,
L. Cif ,
V. Gonzalez Martinez ,
D. Capdevielle ,
A. Ionita ,
B. Biolsi ,
P. Courtet ,
J.P. Boulenger  and
P. Coubes
A. Moura
Affiliation:
Neurosurgery, University Hospital of Montpellier, Montpellier, France
L. Cif
Affiliation:
Neurosurgery, University Hospital of Montpellier, Montpellier, France
V. Gonzalez Martinez
Affiliation:
Neurosurgery, University Hospital of Montpellier, Montpellier, France
D. Capdevielle
Affiliation:
Psychiatry, University Hospital of Montpellier, Montpellier, France
A. Ionita
Affiliation:
Medical Psychology and Psychiatry, University Hospital of Montpellier, Montpellier, France
B. Biolsi
Affiliation:
Neurosurgery, University Hospital of Montpellier, Montpellier, France
P. Courtet
Affiliation:
Medical Psychology and Psychiatry, University Hospital of Montpellier, Montpellier, France
J.P. Boulenger
Affiliation:
Psychiatry, University Hospital of Montpellier, Montpellier, France
P. Coubes
Affiliation:
Neurosurgery, University Hospital of Montpellier, Montpellier, France

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Obsessive compulsive-disorder (OCD) is a group of highly debilitating condition characterized by intrusive troubling thoughts, repetitive, compulsive behaviors or mental rituals. A notable percentage of patients are refractory to pharmacological treatment and cognitive behaviour therapy. Increasing attention has been paid to the efficacy of Deep Brain Stimulation (DBS) therapies in alleviating pharmacoresistant psychiatric disorders including OCD.

Objectives

The aim of this prospective study was to determine the efficacy of DBS using several targets in a pharmacoresistant OCD population with heterogeneous symptoms.

Methods

Five patients (3 males) have been included in the study. Patients were classified according to their prominent features as follows: contamination/cleaning, symmetry/checking, exactness/counting and forbidden thoughts.

The entire surgical procedure was performed under general anaesthesia. Direct targeting based on stereotactic MRI without microelectrode recordings was done. A combination of two of the following targets was simultaneously implanted for all patients: subthalamic nucleus, accumbens nucleus and bed nucleus of stria terminalis, limbic globus pallidus internus.

Patients were assessed pre-and postoperatively using the Yale-Brown Obsessive Compulsive Scale.

Results

Mean age at surgery was of 42.6±12.68 years. Mean follow-up with DBS was of 21±14.88 months.

Mean preoperative Y-BOCS scores was 31.6±2.70 and of 11±7.97 (p=0,057, Wilcoxon signed Rank test).

Conclusion

Subthalamic nucleus and accumbens nucleus targets seem to be comparable in alleviating several subtypes of compulsions (checking, cleaning, counting) as well as obsessions. Further investigations are required to assess the role of limbic globus pallidus in improving pharmacoresitant OCD. Implanted system was well accepted without triggering new obsessions.

Type
Others
Information
European Psychiatry , Volume 25 , Issue S1: 18th European Congress of Psychiatry. February 27, March 2, 2010 - Munich, Germany , 2010 , 25-E821
Copyright
Copyright © European Psychiatric Association 2010
Submit a response

Comments

No Comments have been published for this article.